M22 Photon Rejuvenation is a non-invasive skin beauty treatment that uses strong pulsed light technology to improve skin pigmentation, redness, and enlarged pores through specific wavelengths of light energy. This technology mainly utilizes the principle of selective photothermal action to decompose melanin, stimulate collagen regeneration, and is suitable for various skin problems such as dull skin tone, acne scars, and photoaging.
1. Technical Principle
The core of M22 photon rejuvenation is OPT optimized pulse technology, which precisely controls the pulse energy and pulse width to target different wavelengths of light energy on the deep layers of the skin. 420 nanometer wavelength can kill Propionibacterium acnes, 515 nanometer targets superficial pigments, 560 nanometer improves red blood streaks, 590 nanometer promotes collagen proliferation, and 640 nanometer acts on deep wrinkles. This multi band synergistic effect can avoid the energy fluctuation problem of traditional photon rejuvenation.
2. Adaptive Symptoms
This technique has a significant lightening effect on pigment diseases such as epidermal melasma and sunspots, and can reduce facial flushing caused by capillary dilation, improve post inflammatory erythema such as rosacea. At the same time, it can shrink large pores, reduce fine lines and slight skin sagging, and has a high comprehensive improvement effect on I-III type photoaging skin. Some stubborn acne patients can reduce sebum secretion through treatment courses.
3. Treatment process
Before surgery, clean the face and apply cold gel to protect the skin. During treatment, there will be a slight burning sensation, usually without anesthesia. Each treatment lasts about 15-30 minutes, with an interval of 3-4 weeks for the next session, usually requiring 3-6 courses of treatment. Temporary redness and swelling may occur after surgery, and it is necessary to strengthen moisturizing and sun protection, and avoid using irritating skincare products. Strict avoidance of light and discontinuation of retinoid products should be implemented for two weeks before and after treatment.
4. Taboo population
Pregnant women, patients with photosensitive diseases, and those who have recently been exposed to sunlight are not suitable for treatment. Individuals with scar constitution, history of skin cancer, and active herpes infection should be cautious. When taking photosensitive drugs such as tetracycline antibiotics, or when there are open wounds on the skin or severe acne inflammation, treatment should be temporarily postponed. Patients with diabetes and people with immune deficiency need to be determined after evaluation.
5. Effect Maintenance
Brightening of skin tone can be observed with a single treatment, but the best effect needs to be achieved throughout the entire cycle. The improvement of pigmentation problems usually lasts for 6-12 months, and the collagen regeneration effect will continue for 3-6 months after the end of the treatment. It is recommended to undergo maintenance treatment 1-2 times a year, combined with daily use of skincare products containing vitamin C and niacinamide to prolong the effect. Strict sun protection and a healthy lifestyle are key factors in maintaining therapeutic effects.
Avoid high temperature environment within 24 hours after receiving M22 photon rejuvenation, and use medical repair facial mask to help restore skin barrier. During treatment, it is recommended to increase the intake of vitamin E and zinc, and reduce spicy and stimulating foods. Mild cleansing products should be chosen for daily care, paired with moisturizing creams containing ceramides. The long-term effect is closely related to the individual's skin condition and care habits. Before and after treatment, it is necessary to maintain communication with professional physicians and adjust the plan according to skin reactions. For patients with combined skin problems, a combination of radiofrequency or mesodermal therapy can be considered for comprehensive improvement.
Comments (0)
Leave a Comment
No comments yet
Be the first to share your thoughts!